Trade Mark Journal No.2025/042 17 October 2025

UK00004276351 10 October 2025 (5)

DHANLYRA

International priority date claimed: 25 September 2025 (Switzerland) (14301/2025)

Class 5: Anti-inflammatories; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention and treatment of inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiac diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune-mediated diseases and disorders; pharmaceutical preparations for the prevention and treatment of rare diseases and disorders.

Kiniksa Pharmaceuticals, GmbH

Representative: HGF Limited